Cost-efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics with Greatest Risk for Cardiovascular Disease. Cardiology and Cardiovascular Medicine, v. 10, n. 2, p. 71–78, 16 Apr.2026.